Slowing Disease Progression in Amyotrophic Lateral Sclerosis: A Review of Guidelines and Current and Emerging Therapies
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
4
Defunding Co-Payment Assistance Disrupted nAMD Care
5